Stockreport

Evaxion expands R&D pipeline with new AI-designed precision cancer vaccine candidate

Evaxion Biotech A/S - American Depositary Share  (EVAX) 
PDF Evaxion introduces EVX-04, a novel vaccine candidate targeting multiple non-conventional ERV tumor antigens, developed with our AI-Immunology™ platformEVX-04 is a therap [Read more]